Imbed Bio Wins 2016 Wound Care Innovation Award in Bremen, Germany
Bremen, Germany (May 12, 2016) – Imbed Biosciences announces that its microfilm wound dressing technology has today won the annual 2016 Wound Care Innovation Award at the European Wound Management Association (EWMA) conference in Bremen, Germany. About 6,000 medical professionals attended the conference, which is the largest such annual gathering in Europe. In total, more than 1000 scientific presentations took place during the three-day conference. More than 180 companies exhibited their newest products.
Imbed was one of the five finalists invited to present at the Wound Care Innovation Symposium for the grand prize, sponsored by CMC Consulting Group, EWMA and Lohmann & Rauscher. Each company made a 10 minutes presentation of their technological innovations before an esteemed panel of judges from the industry. The other finalist companies were Kerecis Ltd (Iceland), Birken AG (Germany), Inotec AMD Ltd (UK), and NuTech Medical (AL, USA).
Imbed presented its microfilm wound dressing technology platform, which is a transparent, thin, synthetic hydrogel film with a coating of ionic and metallic silver. When placed on a moist wound, microfilm dressing absorbs wound moisture and forms a conforming gel sheet that can provide antimicrobial barrier to infections for several days. Microfilm dressings contain 100 times less silver than competitor silver-based wound dressings in clinics, allowing them to be used on day one of any wound management plan without fear of silver staining or toxicity. The product is currently under review for regulatory clearance for human use.
About Imbed Biosciences Inc.
Imbed Biosciences is a privately held medical device company, located in Madison, WI. Imbed’s vision is to develop next-generation medical devices that can reduce patient pain and costs for management of burns, chronic wounds, hernia meshes, gastro-intestinal defects, and dural membranes. Company has a portfolio of products in development based on its synthetic and biodegradable thin films platform that present bioactive molecules on tissue surfaces to manage wound infections, biofilms, and local pain and promote wound healing. For more information, please visit www.www.imbedbio.com.
Ankit Agarwal, CEO
Imbed Biosciences Inc.